General Information of the Compound
Compound ID |
CP0145327
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
4-pyridin-2-yl-N-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-amine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C15H10F3N3S
|
||||||||||||||||||
Molecular Weight |
321.327
|
||||||||||||||||||
Canonical SMILES |
FC(F)(F)c1ccc(Nc2nc(cs2)-c2ccccn2)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C15H10F3N3S/c16-15(17,18)10-4-6-11(7-5-10)20-14-21-13(9-22-14)12-3-1-2-8-19-12/h1-9H,(H,20,21)
Show/Hide
|
||||||||||||||||||
InChIKey |
FEKMHFSHIMPSFV-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02259, Neuropeptide Y receptor type 1
Protein ID: PT01611, Neuropeptide Y receptor type 2
Protein ID: PT01795, Neuropeptide Y receptor type 5